0000000000542811

AUTHOR

C. Fernández

showing 8 related works from this author

Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis

2018

Autoimmune hepatitis (AIH) frequently affects women of childbearing age in whom the desire to have a family raises the question regarding the potential risks for the fetus and the mother. The information on AIH in pregnant patients is scarce.1 The aims of this study were (1) to identify the risk factors associated with flares in pregnant patients diagnosed with AIH, (2) to determine the course of AIH in patients with pregnancy-related flares, and (3) to describe the outcome of AIH diagnosed in the postpartum period.

AdultPediatricsmedicine.medical_specialtyAutoimmune hepatitisCohort Studies03 medical and health sciences0302 clinical medicinePregnancyimmune system diseasesAzathioprinemedicineHumansIn patientAspartate AminotransferasesGlucocorticoidsreproductive and urinary physiologyRetrospective StudiesPregnancyHepatologybusiness.industryPostpartum PeriodPregnancy OutcomeGastroenterologyAlanine TransaminaseHypertension Pregnancy-InducedSymptom Flare Upmedicine.diseasedigestive system diseasesAbortion SpontaneousPregnancy ComplicationsDiabetes GestationalHepatitis Autoimmune030220 oncology & carcinogenesisChildbearing agePrednisoneDrug Therapy CombinationFemale030211 gastroenterology & hepatologyPresentation (obstetrics)businessImmunosuppressive AgentsPostpartum periodClinical Gastroenterology and Hepatology
researchProduct

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.

2015

Background and rational. Telaprevir-based therapy (TBT) has been extensively evaluated in clinical trials. So we designed a study to compare the efficacy and safety of TBT between patients with moderate fibrosis and those suffering from advanced fibrosis in clinical practice. A multicenter observational and ambispective study was conducted. It included 582 patients with chronic hepatitis C genotype 1, 214 with fibrosis F2, and 368 with F3/F4 (F3: 148; F4: 220). Results. The mean patient age was 55 years, 67% male. Type of prior response was 22% naive, 57% relapsers, and 21% partial/null responders, 69% had high viral load (> 800,000 IU/mL). HCV genotypes were 1a (19%), 1b (69%), and 1 (12%)…

Liver CirrhosisMaleTime FactorsSpecialties of internal medicineHepacivirusGastroenterologySeverity of Illness IndexTelaprevirFibrosisRisk FactorsGenotypeGeneral MedicineMiddle AgedViral LoadTreatment OutcomeRC581-951Hepatitis C genotype 1RNA ViralDrug Therapy CombinationFemaleTelaprevir triple therapyModerate fibrosisViral loadOligopeptidesmedicine.drugAdultmedicine.medical_specialtyGenotypeAntiviral AgentsSafety and efficacyYoung AdultInternal medicinemedicineHumansAdverse effectAgedHepatologybusiness.industryInterleukinsHepatitis C Chronicmedicine.diseaseSurgeryDiscontinuationClinical trialSpainObservational studyInterferonsbusinessBiomarkersAnnals of hepatology
researchProduct

Association Between Tumor Egfr and Kras Mutation Status and Clinical Outcomes in Nsclc Patients Randomized to Sorafenib Plus Best Supportive Care (BS…

2012

ABSTRACT Background Tumor EGFR and KRas mutations are both predictive and prognostic biomarkers in patients with advanced NSCLC. We analyzed the correlation between these biomarkers and treatment outcomes in a phase III trial of 3rd/4th line sorafenib in patients with NSCLC. Methods The global, randomized, placebo-controlled MISSION trial enrolled 703 patients with advanced relapsed/refractory NSCLC of predominantly non-squamous histology. The primary study endpoint was overall survival (OS). EGFR and KRas mutations were analyzed in archival tumor samples and in circulating tumor DNA isolated from plasma. Results Tumor and/or plasma mutation data were available from 347 patients (49%). EGFR…

OncologySorafenibmedicine.medical_specialtyProportional hazards modelbusiness.industryHematologymedicine.disease_causePlacebomedicine.diseaseBreast cancerOncologyEgfr mutationInternal medicineMedicineBiomarker (medicine)KRASStage (cooking)businessmedicine.drugAnnals of Oncology
researchProduct

Role of glutathione in Thiobencarb resistance in the European eel Anguilla anguilla.

2000

Glutathione-dependent defense against xenobiotic toxicity is a multifaceted phenomenon that has been well characterized in mammals. In the present study, eels of species Anguilla anguilla were exposed to 15 ppm of the herbicide thiobencarb (S-4-chlorobenzyl diethylthiocarbamate) for 96 h. Eels exposed to the pesticide were grouped in 24-h intervals according to their time of death, while surviving intoxicated eels constituted another group (live animals). Glutathione content (GSx, GSH, GSSG) was determined in liver and muscle tissues of the dead and live (intoxicated) animals and compared to control values (nonexposed eels). The fish that died before 96 h of exposure were considered suscept…

endocrine systemmedicine.medical_specialtyanimal structuresHealth Toxicology and MutagenesisMedizinDrug Resistancechemistry.chemical_compoundAnguillidaeThiocarbamatesInternal medicinemedicineAnimalsEelsbiologyGlutathione DisulfideEcologyHerbicidesMusclesPublic Health Environmental and Occupational HealthAquatic animalGeneral MedicineGlutathionePesticidebiology.organism_classificationPollutionGlutathioneEndocrinologychemistryLiverToxicityGlutathione disulfideXenobioticHomeostasisEcotoxicology and environmental safety
researchProduct

Impacto pronóstico a largo plazo de la anticoagulación en pacientes en hemodiálisis con fibrilación auricular

2018

Resumen: Introducción y objetivos: La evidencia de la eficacia y seguridad de la anticoagulación oral con dicumarínicos en pacientes en hemodiálisis con fibrilación auricular (FA) es controvertida. El objetivo de nuestro estudio es evaluar las implicaciones a nivel pronóstico a largo plazo de la anticoagulación con dicumarínicos en una cohorte de pacientes con FA no valvular en programa de hemodiálisis debido a insuficiencia renal terminal. Métodos: Estudio observacional retrospectivo con inclusión consecutiva de 74 pacientes en hemodiálisis con FA. El periodo de inclusión fue de enero de 2005 a octubre de 2016. Las variables principales fueron mortalidad por todas las causas, reingresos no…

Gynecologymedicine.medical_specialtyHemodiálisisbusiness.industrymedicine.medical_treatmentAnticoagulación030232 urology & nephrologyAtrial fibrillation030204 cardiovascular system & hematologylcsh:Diseases of the genitourinary system. Urologylcsh:RC870-923medicine.diseaseAtrial fibrillationFibrilación auricular03 medical and health sciencesAnticoagulation0302 clinical medicineNephrologyHemodialysisMedicineEnfermeríaHemodialysisbusiness
researchProduct

Liver energy metabolism of Anguilla anguilla after exposure to fenitrothion.

1998

This paper deals with the effect of fenitrothion (0.04 mg/liter) on the energy metabolism of the European eel, Anguilla anguilla, and its recovery from intoxication. Various parameters such as glycogen, lactate, proteins, total lipids, and glucose in eel liver and blood were analyzed after 2, 8, 12, 24, 32, 48, 56, 72, and 96 h of fenitrothion exposure. Subsequently, the fish were allowed recovery periods of 8, 12, 24, 48, 72, 96, 144, and 192 h in clean water, and the same parameters were evaluated. Liver glycogen and lipid contents decreased significantly during the exposure, while blood glucose levels increased markedly. Liver and blood lactate values increased during pesticide exposure,…

medicine.medical_specialtyInsecticidesTime FactorsHealth Toxicology and MutagenesisFenitrothionchemistry.chemical_compoundAnguillidaeInternal medicinemedicineAnimalsPollutantGlycogenbiologyPublic Health Environmental and Occupational HealthLiterGeneral MedicineMetabolismFenitrothionPesticidebiology.organism_classificationAnguillaLipid MetabolismPollutionEndocrinologychemistryLiverToxicityEnergy MetabolismWater Pollutants ChemicalEcotoxicology and environmental safety
researchProduct

Short-term exposure to sublethal tebuconazole induces physiological impairment in male zebrafish (Danio rerio).

2010

Abstract The aim of the present study was to assess the physiological response of male zebrafish Danio rerio to the fungicide tebuconazole and recovery in fungicide-free water. Acute toxicity tests were carried out and the median lethal concentration (LC 50 ) from 24 to 96 h was calculated. The fish were exposed to a sublethal fungicide concentration of 230 μg/L for 7 or 14 days and allowed to recover for 7 or 14 more days, respectively. Whole-body levels of vitellogenins, triglycerides, cholesterol, glucose, lactate and proteins as well as the activities γ-glutamil transpeptidase (γ-GT), alanin aminotransferase (AlAT), alkaline phosphatase (AP) and lactate dehydrogenase (LDH) were assayed;…

Malemedicine.medical_specialtyTime FactorsHealth Toxicology and MutagenesisBiologyLethal Dose 50chemistry.chemical_compoundVitellogeninVitellogeninsFish physiologyInternal medicineLactate dehydrogenasemedicineToxicity Tests AcuteAnimalsZebrafishTebuconazoleBody WeightPublic Health Environmental and Occupational HealthGeneral MedicineEnvironmental ExposureRecovery of FunctionTriazolesLipid MetabolismPollutionAcute toxicityEnzymesFungicides IndustrialEndocrinologyGlucosechemistryToxicitybiology.proteinLactatesAlkaline phosphataseVitellogeninsBiomarkersEcotoxicology and environmental safety
researchProduct

Evaluation of the risk factors of asymptomatic vertebral fractures in postmenopausal women with osteopenia at the femoral neck

2016

To identify risk factors of asymptomatic vertebral fracture (aVF) in postmenopausal women with osteopenia at the femoral neck and to evaluate the association between the number of aVFs and the risk of major and hip osteoporotic fracture calculated with the FRAX(®) algorithm.Epidemiological case-series study with data collected transversally.728 postmenopausal women with osteopenia were included: 284 (39.0%) had aVF, of whom 200 (70.4%) had prior fragility fractures (FF). The likelihood of having an osteoporotic fracture in the next 10 years increased significantly with the number of aVF. The percentage of women with height loss, which was assessed as the difference between the greatest heig…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyFRAXBone density030209 endocrinology & metabolismRisk AssessmentAsymptomaticGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineBone DensityRisk FactorsEpidemiologymedicineHumanscardiovascular diseases030212 general & internal medicineAgedRetrospective StudiesFemoral neckFemur NeckHip Fracturesbusiness.industryObstetrics and GynecologyRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryPostmenopauseOsteopeniaBone Diseases Metabolicmedicine.anatomical_structureSpainMultivariate AnalysisSpinal FracturesFemalemedicine.symptombusinessRisk assessmentAlgorithmsOsteoporotic Fractures
researchProduct